AMBRISENTAN for Substance abuse: Side Effects & Safety Data
Drink Less in 7 Days — Without Willpower
Clinically proven audio program. Just 25 min/day. Already helped 108,000+ people.
There are 13 adverse event reports in the FDA FAERS database where AMBRISENTAN was used for Substance abuse.
Most Reported Side Effects for AMBRISENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 13,367 | 15.5% | 652 | 6,217 |
| Death | 7,497 | 8.7% | 7,442 | 1,241 |
| Headache | 7,325 | 8.5% | 203 | 1,884 |
| Pneumonia | 4,693 | 5.4% | 368 | 3,802 |
| Dizziness | 4,561 | 5.3% | 93 | 1,261 |
| Fatigue | 4,436 | 5.2% | 145 | 1,312 |
| Diarrhoea | 4,312 | 5.0% | 168 | 1,512 |
| Nausea | 3,986 | 4.6% | 153 | 1,297 |
| Fluid retention | 3,927 | 4.6% | 212 | 2,212 |
| Malaise | 3,839 | 4.5% | 214 | 1,491 |
| Peripheral swelling | 3,461 | 4.0% | 128 | 1,107 |
| Cough | 3,067 | 3.6% | 85 | 899 |
| Nasal congestion | 3,019 | 3.5% | 36 | 423 |
| Oedema peripheral | 2,959 | 3.4% | 114 | 882 |
| Oedema | 2,651 | 3.1% | 109 | 923 |
Other Indications for AMBRISENTAN
Product used for unknown indication (35,884)
Pulmonary arterial hypertension (27,852)
Pulmonary hypertension (18,885)
Scleroderma (1,547)
Cor pulmonale chronic (879)
Connective tissue disorder (857)
Heart disease congenital (772)
Chronic obstructive pulmonary disease (460)
Portopulmonary hypertension (428)
Sleep apnoea syndrome (352)
Other Drugs Used for Substance abuse
ARIPIPRAZOLE (58)
NALTREXONE (54)
BUPRENORPHINE\NALOXONE (36)
METHADONE (33)
FENTANYL (20)
COCAINE (19)
QUETIAPINE (18)
ALCOHOL (17)
BUPRENORPHINE (17)
NITROUS (17)